Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) FCF Margin: 2016-2025

Historic FCF Margin for Collegium Pharmaceutical (COLL) over the last 10 years, with Sep 2025 value amounting to 37.38%.

  • Collegium Pharmaceutical's FCF Margin rose 4318.00% to 37.38% in Q3 2025 from the same period last year, while for Sep 2025 it was 38.21%, marking a year-over-year increase of 610.00%. This contributed to the annual value of 32.20% for FY2024, which is 1619.00% down from last year.
  • Per Collegium Pharmaceutical's latest filing, its FCF Margin stood at 37.38% for Q3 2025, which was down 2.91% from 38.50% recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's FCF Margin registered a high of 130.41% during Q4 2021, and its lowest value of -30.36% during Q1 2022.
  • Moreover, its 3-year median value for FCF Margin was 42.35% (2024), whereas its average is 39.18%.
  • Per our database at Business Quant, Collegium Pharmaceutical's FCF Margin skyrocketed by 10,275bps in 2021 and then slumped by 7,997bps in 2022.
  • Collegium Pharmaceutical's FCF Margin (Quarterly) stood at 130.41% in 2021, then tumbled by 7,997bps to 50.44% in 2022, then plummeted by 158bps to 48.87% in 2023, then plummeted by 266bps to 46.21% in 2024, then surged by 4,318bps to 37.38% in 2025.
  • Its FCF Margin stands at 37.38% for Q3 2025, versus 38.50% for Q2 2025 and 30.72% for Q1 2025.